Global Cancer Gene Therapy Market Research Report 2017

Publisher Name :
Date: 04-Dec-2017
No. of pages: 120
Inquire Before Buying

In this report, the global Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Gene Therapy in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Cancer Gene Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Adaptimmune

- GlaxoSmithKline

- Bluebird bio

- Merck

- Celgene

- Shanghai Sunway Biotech

- BioCancell

- Shenzhen SiBiono GeneTech

- SynerGene Therapeutics

- OncoGenex Pharmaceuticals

- Genelux Corporation

- Cell Genesys

- Advantagene

- GenVec

- BioCancell

- Celgene

- Epeius Biotechnologies

- Introgen Therapeutics

- Ziopharm Oncology

- Shenzhen SiBiono GeneTech

- Altor Bioscience

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Gene Induced Immunotherapy

- Oncolytic Virotherapy

- Gene Transfer

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospitals

- Diagnostics Centers

- Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Cancer Gene Therapy Market Research Report 2017

Table of Contents
Global Cancer Gene Therapy Market Research Report 2017
1 Cancer Gene Therapy Market Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Cancer Gene Therapy Segment by Type (Product Category)
1.2.1 Global Cancer Gene Therapy Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Cancer Gene Therapy Production Market Share by Type (Product Category) in 2016
1.2.3 Gene Induced Immunotherapy
1.2.4 Oncolytic Virotherapy
1.2.5 Gene Transfer
1.3 Global Cancer Gene Therapy Segment by Application
1.3.1 Cancer Gene Therapy Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Global Cancer Gene Therapy Market by Region (2012-2022)
1.4.1 Global Cancer Gene Therapy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Gene Therapy (2012-2022)
1.5.1 Global Cancer Gene Therapy Revenue Status and Outlook (2012-2022)
1.5.2 Global Cancer Gene Therapy Capacity, Production Status and Outlook (2012-2022)
2 Global Cancer Gene Therapy Market Competition by Manufacturers
2.1 Global Cancer Gene Therapy Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Cancer Gene Therapy Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Cancer Gene Therapy Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Gene Therapy Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Gene Therapy Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Gene Therapy Market Competitive Situation and Trends
2.5.1 Cancer Gene Therapy Market Concentration Rate
2.5.2 Cancer Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Cancer Gene Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Cancer Gene Therapy Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Gene Therapy Production and Market Share by Region (2012-2017)
3.3 Global Cancer Gene Therapy Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Cancer Gene Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Cancer Gene Therapy Consumption by Region (2012-2017)
4.2 North America Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)
5 Global Cancer Gene Therapy Production, Revenue (Value), Price Trend by Type
5.1 Global Cancer Gene Therapy Production and Market Share by Type (2012-2017)
5.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Gene Therapy Price by Type (2012-2017)
5.4 Global Cancer Gene Therapy Production Growth by Type (2012-2017)
6 Global Cancer Gene Therapy Market Analysis by Application
6.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Cancer Gene Therapy Manufacturers Profiles/Analysis
7.1 Adaptimmune
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Gene Therapy Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Adaptimmune Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Gene Therapy Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 GlaxoSmithKline Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Bluebird bio
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Gene Therapy Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bluebird bio Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Merck
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Gene Therapy Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Merck Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Celgene
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Gene Therapy Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Celgene Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Shanghai Sunway Biotech
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Gene Therapy Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 BioCancell
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Gene Therapy Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 BioCancell Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Shenzhen SiBiono GeneTech
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Gene Therapy Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 SynerGene Therapeutics
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Gene Therapy Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 SynerGene Therapeutics Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 OncoGenex Pharmaceuticals
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cancer Gene Therapy Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Genelux Corporation
7.12 Cell Genesys
7.13 Advantagene
7.14 GenVec
7.15 BioCancell
7.16 Celgene
7.17 Epeius Biotechnologies
7.18 Introgen Therapeutics
7.19 Ziopharm Oncology
7.20 Shenzhen SiBiono GeneTech
7.21 Altor Bioscience
8 Cancer Gene Therapy Manufacturing Cost Analysis
8.1 Cancer Gene Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Gene Therapy
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cancer Gene Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Cancer Gene Therapy Market Forecast (2017-2022)
12.1 Global Cancer Gene Therapy Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Cancer Gene Therapy Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2017-2022)
12.2 Global Cancer Gene Therapy Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Gene Therapy Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Gene Therapy Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Cancer Gene Therapy
Figure Global Cancer Gene Therapy Production (Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Cancer Gene Therapy Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Gene Induced Immunotherapy
Table Major Manufacturers of Gene Induced Immunotherapy
Figure Product Picture of Oncolytic Virotherapy
Table Major Manufacturers of Oncolytic Virotherapy
Figure Product Picture of Gene Transfer
Table Major Manufacturers of Gene Transfer
Figure Global Cancer Gene Therapy Consumption (Units) by Applications (2012-2022)
Figure Global Cancer Gene Therapy Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Centers Examples
Table Key Downstream Customer in Diagnostics Centers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure Global Cancer Gene Therapy Market Size (Million USD), Comparison (Units) and CAGR (%) by Regions (2012-2022)
Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Gene Therapy Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Cancer Gene Therapy Capacity, Production (Units) Status and Outlook (2012-2022)
Figure Global Cancer Gene Therapy Major Players Product Capacity (Units) (2012-2017)
Table Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers (2012-2017)
Table Global Cancer Gene Therapy Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2016
Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2017
Figure Global Cancer Gene Therapy Major Players Product Production (Units) (2012-2017)
Table Global Cancer Gene Therapy Production (Units) of Key Manufacturers (2012-2017)
Table Global Cancer Gene Therapy Production Share by Manufacturers (2012-2017)
Figure 2016 Cancer Gene Therapy Production Share by Manufacturers
Figure 2017 Cancer Gene Therapy Production Share by Manufacturers
Figure Global Cancer Gene Therapy Major Players Product Revenue (Million USD) (2012-2017)
Table Global Cancer Gene Therapy Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Cancer Gene Therapy Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Cancer Gene Therapy Revenue Share by Manufacturers
Table 2017 Global Cancer Gene Therapy Revenue Share by Manufacturers
Table Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Cancer Gene Therapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Gene Therapy Product Category
Figure Cancer Gene Therapy Market Share of Top 3 Manufacturers
Figure Cancer Gene Therapy Market Share of Top 5 Manufacturers
Table Global Cancer Gene Therapy Capacity (Units) by Region (2012-2017)
Figure Global Cancer Gene Therapy Capacity Market Share by Region (2012-2017)
Figure Global Cancer Gene Therapy Capacity Market Share by Region (2012-2017)
Figure 2016 Global Cancer Gene Therapy Capacity Market Share by Region
Table Global Cancer Gene Therapy Production by Region (2012-2017)
Figure Global Cancer Gene Therapy Production (Units) by Region (2012-2017)
Figure Global Cancer Gene Therapy Production Market Share by Region (2012-2017)
Figure 2016 Global Cancer Gene Therapy Production Market Share by Region
Table Global Cancer Gene Therapy Revenue (Million USD) by Region (2012-2017)
Table Global Cancer Gene Therapy Revenue Market Share by Region (2012-2017)
Figure Global Cancer Gene Therapy Revenue Market Share by Region (2012-2017)
Table 2016 Global Cancer Gene Therapy Revenue Market Share by Region
Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate (2012-2017)
Table Global Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table North America Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Europe Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table China Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Japan Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table India Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Global Cancer Gene Therapy Consumption (Units) Market by Region (2012-2017)
Table Global Cancer Gene Therapy Consumption Market Share by Region (2012-2017)
Figure Global Cancer Gene Therapy Consumption Market Share by Region (2012-2017)
Figure 2016 Global Cancer Gene Therapy Consumption (Units) Market Share by Region
Table North America Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table Europe Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table China Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table Japan Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table Southeast Asia Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table India Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)
Table Global Cancer Gene Therapy Production (Units) by Type (2012-2017)
Table Global Cancer Gene Therapy Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure 2016 Production Market Share of Cancer Gene Therapy by Type
Table Global Cancer Gene Therapy Revenue (Million USD) by Type (2012-2017)
Table Global Cancer Gene Therapy Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Gene Therapy by Type (2012-2017)
Figure 2016 Revenue Market Share of Cancer Gene Therapy by Type
Table Global Cancer Gene Therapy Price (K USD/Unit) by Type (2012-2017)
Figure Global Cancer Gene Therapy Production Growth by Type (2012-2017)
Table Global Cancer Gene Therapy Consumption (Units) by Application (2012-2017)
Table Global Cancer Gene Therapy Consumption Market Share by Application (2012-2017)
Figure Global Cancer Gene Therapy Consumption Market Share by Applications (2012-2017)
Figure Global Cancer Gene Therapy Consumption Market Share by Application in 2016
Table Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)
Table Adaptimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adaptimmune Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Production Market Share (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Production Market Share (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Bluebird bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluebird bio Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Production Market Share (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Merck Cancer Gene Therapy Production Market Share (2012-2017)
Figure Merck Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Celgene Cancer Gene Therapy Production Market Share (2012-2017)
Figure Celgene Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Shanghai Sunway Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Market Share (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Market Share (2012-2017)
Table BioCancell Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioCancell Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure BioCancell Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure BioCancell Cancer Gene Therapy Production Market Share (2012-2017)
Figure BioCancell Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Market Share (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share (2012-2017)
Table SynerGene Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SynerGene Therapeutics Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Production Market Share (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Market Share (2012-2017)
Table OncoGenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Growth Rate (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Market Share (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Gene Therapy Price (Million USD) and Trend Forecast (2017-2022)
Table Global Cancer Gene Therapy Production (Units) Forecast by Region (2017-2022)
Figure Global Cancer Gene Therapy Production Market Share Forecast by Region (2017-2022)
Table Global Cancer Gene Therapy Consumption (Units) Forecast by Region (2017-2022)
Figure Global Cancer Gene Therapy Consumption Market Share Forecast by Region (2017-2022)
Figure North America Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Europe Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure China Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Figure India Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)
Table Global Cancer Gene Therapy Production (Units) Forecast by Type (2017-2022)
Figure Global Cancer Gene Therapy Production (Units) Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Price Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2017-2022)
Figure Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2500 Onwards        Pages: 1829
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2017, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) pipeline landscape. Acute myelocytic leukemia (AML), also known as acute myelogenous leukemia is a type of cancer that affects the blood and the bone marrow. Immature white blood cell......
  • Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2500 Onwards        Pages: 1226
    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2017, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape. Multiple myeloma is a type of cancer that is caused by malignant plasma cells that proliferate in the bone marrow and produce abnormally high amounts of a special pr......
  • Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2500 Onwards        Pages: 1575
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape. Glioblastoma also known as glioblastoma multiforme is a fast-growing glioma that develops from star-shaped glial cells that support the health of the nerve cells within the brain. Symptoms include headaches, blurred vision, n......
  • Colon Cancer - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2500 Onwards        Pages: 773
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease - pipeline guide Colon Cancer Pipeline Review, H2 2017, provides an overview of the Colon Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The fol......
  • Non-Small Cell Lung Cancer - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2500 Onwards        Pages: 2678
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H2 2017, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in later s......
  • Global Breast Cancer Monoclonal Antibodies Market Research Report 2017
    Published: 12-Dec-2017        Price: US 2900 Onwards        Pages: 129
    In this report, the global Breast Cancer Monoclonal Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Breast Cancer Monoclonal Antibodies in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 524
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades......
  • Ewing Sarcoma - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 326
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Pipeline Review, H2 2017, provides an overview of the Ewing Sarcoma (Oncology) pipeline landscape. Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but usually develops during puberty, when bones are growing rapidly. There are few symptoms. The ......
  • Meningioma - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 229
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningioma - Pipeline Review, H2 2017, provides an overview of the Meningioma (Oncology) pipeline landscape. A meningioma is a type of tumor that develops from the meninges, the membrane that surrounds the brain and spinal cord. There are three layers of meninges, called the dura mater, arachnoid and pia mater. Most meningiomas (90%) are categorized as benign tumors, wi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs